(Q40573309)

21 September 2017

Hapten-directed targeting to single-chain antibody receptors (English)

1 reference

21 September 2017

Tian-Lu Cheng

1

1 reference

21 September 2017

Kuang-Wen Liao

2

1 reference

21 September 2017

Shey-Cherng Tzou

3

1 reference

21 September 2017

Chiu-Min Cheng

4

1 reference

21 September 2017

Bing-Mae Chen

5

1 reference

21 September 2017

Steve R Roffler

6

1 reference

21 September 2017

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

5

1 reference

21 September 2017

380-388

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700712

21 September 2017

0 references

cites work

Monoclonal antibody drug conjugates in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Experimental radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Activation of lymphocytes by anti-CD3 single-chain antibody dimers expressed on the plasma membrane of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Receptor-mediated targeting of fluorescent probes in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Design of transgenes for efficient expression of active chimeric proteins on mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Enantioselectivity of recombinant Rhizomucor miehei lipase in the ring opening of oxazolin-5(4H)-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Gene therapy: designer promoters for tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

Somatic mutation and the maturation of immune response to 2-phenyl oxazolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

T cell activation by monoclonal antibodies bound to tumor cells by a cell surface displayed single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Cell surface display of a single-chain antibody for attaching polypeptides.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Characterization of an antineoplastic glucuronide prodrug

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

4-alkylidene oxazolones as substrates and inhibitors for sensitive assays of the normality of active sites and the catalytic properties of hydrolases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Cure of malignant ascites and generation of protective immunity by monoclonal antibody-targeted activation of a glucuronide prodrug in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700712

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700712

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference